Similar articles

• Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.

  Schödel F, Kelly SM, Peterson D, Milich D, Hughes J, Tinge S, Wirtz R, Curtiss R 3rd. Schödel F, et al. Dev Biol Stand. 1994;82:151-8. Dev Biol Stand. 1994. PMID: 7958469 Review.
• Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.

  Tennant SM, Schmidlein P, Simon R, Pasetti MF, Galen JE, Levine MM. Tennant SM, et al. Infect Immun. 2015 Dec;83(12):4504-12. doi: 10.1128/IAI.00924-15. Epub 2015 Sep 8. Infect Immun. 2015. PMID: 26351285 Free PMC article.
• The virulence for gnotobiotic pigs of live attenuated vaccine strains of Salmonella enterica serovars Typhimurium and Enteritidis.

  Barrow PA, Page K, Lovell MA. Barrow PA, et al. Vaccine. 2001 May 14;19(25-26):3432-6. doi: 10.1016/s0264-410x(01)00065-2. Vaccine. 2001. PMID: 11348707
• Avirulent Salmonella typhimurium delta cya delta crp oral vaccine strains expressing a streptococcal colonization and virulence antigen.

  Curtiss R 3rd, Goldschmidt RM, Fletchall NB, Kelly SM. Curtiss R 3rd, et al. Vaccine. 1988 Apr;6(2):155-60. doi: 10.1016/s0264-410x(88)80020-3. Vaccine. 1988. PMID: 3291452 Review.
• Recombinant Salmonella vectors in vaccine development.

  Curtiss R 3rd, Kelly SM, Tinge SA, Tacket CO, Levine MM, Srinivasan J, Koopman M. Curtiss R 3rd, et al. Dev Biol Stand. 1994;82:23-33. Dev Biol Stand. 1994. PMID: 7958478 Review.